Freakonomics Radio
It regulates 20 percent of the U.S. economy, and its commissioner has an aggressive agenda — faster drug approvals, healthier food, cures for diabetes and cancer. How much can he deliver? (Part two of “The Freakonomics Radio Guide to Getting Better.”)
- SOURCES:
- Marty Makary, commissioner of the Food and Drug Administration.
- RESOURCES:
- “Clinical Trials Affected by Research Grant Terminations at the National Institutes of Health,” by Vishal Patel, Michael Liu, and Anupam Jena (JAMA Internal Medicine, 2025).
- “What the evidence tells us about Tylenol, leucovorin, and autism,” by Matthew Herper (STAT, 2025).
- “I Run the F.D.A. Pharma Ads Are Hurting Americans.” by Marty Makary (New York Times, 2025).
- Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health, by Marty Makary (2024).
- EXTRAS:
- “Are You Really Allergic to Penicillin?” by Freakonomics Radio (2025).
- “How to Fix the Hot Mess of U.S. Healthcare,” by Freakonomics Radio (2021).
- “Bad Medicine, Part 3: Death by Diagnosis,” by Freakonomics Radio (2016).
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
638. Are You Ready for the Elder Swell?
In the U.S., there will soon be more people over 65 than there are under 18 — and it’s not just lifespan that’s improving, it’s “healthspan” too. Unfortunately, the American approach to aging is stuck…
What Do Medieval Nuns and Bo Jackson Have in Common? (Update)
In this episode from 2013, we look at whether spite pays — and if it even exists. SOURCES: Benedikt Herrmann, research officer at the European Commission. Steve Levitt, co-author of Freakonomics and host of…
637. What It’s Like to Be Middle-Aged (in the Middle Ages)
The simplicity of life back then is appealing today, as long as you don’t mind Church hegemony, the occasional plague, trial by gossip — and the lack of ibuprofen. (Part two of a three-part series,…
636. Why Aren’t We Having More Babies?
For decades, the great fear was overpopulation. Now it’s the opposite. How did this happen — and what’s being done about it? (Part one of a three-part series, “Cradle to Grave.”) SOURCES: Matthias Doepke,…
An Economics Lesson from a Talking Pencil (Update)
A famous essay argues that “not a single person on the face of this earth” knows how to make a pencil. How true is that? In this 2016 episode, we looked at what pencil-making can…
635. Can a Museum Be the Conscience of a Nation?
Nicholas Cullinan, the new director of the British Museum, seems to think so. “I’m not afraid of the past,” he says — which means talking about looted objects, the basement storerooms, and the leaking roof.…
634. “Fault-Finder Is a Minimum-Wage Job”
Austan Goolsbee, president of the Federal Reserve Bank of Chicago, is less reserved than the average banker. He explains why vibes are overrated, why the Fed’s independence is non-negotiable, and why tariffs could bring the…
633. The Most Powerful People You’ve Never Heard Of
Just beneath the surface of the global economy, there is a hidden layer of dealmakers for whom war, chaos, and sanctions can be a great business opportunity. Javier Blas and Jack Farchy, the authors of…
How to Succeed at Failing, Part 4: Extreme Resiliency (Update)
Everyone makes mistakes. How do we learn from them? Lessons from the classroom, the Air Force, and the world’s deadliest infectious disease. SOURCES: Will Coleman, founder and C.E.O. of Alto. Amy Edmondson, professor of…
How to Succeed at Failing, Part 3: Grit vs. Quit (Update)
Giving up can be painful. That’s why we need to talk about it. Today: stories about glitchy apps, leaky paint cans, broken sculptures — and a quest for the perfect bowl of ramen. SOURCES:…